Patents Assigned to Abbott Rapid Diagnostics International Unlimited Company
  • Patent number: 11992843
    Abstract: A device for detecting an analyte in a sample is provided, which comprises: a collecting chamber containing an opening for collecting a liquid sample; a detecting element for detecting an analyte in the liquid sample; and a lid for covering the opening of the collecting chamber. The device further comprises an indicating device thereon to indicate whether or not the lid covers at an appointed position. The operation of the device is very simple.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 28, 2024
    Assignee: Abbott Rapid Diagnostics International Unlimited Company
    Inventors: Haipeng Hu, Jianfeng Wang
  • Patent number: 11988671
    Abstract: The present disclosure relates to methods of detecting a protein from the SARS-CoV-2 virus, or a fragment thereof, in a sample obtained from a subject using a first antibody or antigen-binding fragment thereof that binds to a protein from the SARS-CoV-2 virus, or a fragment thereof, and a second antibody or antigen-binding fragment thereof which binds to a protein from the SARS-CoV-2 virus, or a fragment thereof.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 21, 2024
    Assignee: Abbott Rapid Diagnostics International Unlimited Company
    Inventors: Lawrence B. Blyn, Mijung Ji, Stephen Kovacs, Anthony S. Muerhoff, Stacey P. Huth, Carsten Buenning, Tao Xin, Donabel Roberts, Sung Hee Kim, Sang Yong Park, Robert N. Ziemann
  • Patent number: 11814669
    Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: November 14, 2023
    Assignee: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
    Inventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
  • Patent number: 11428686
    Abstract: Provided herein is technology relating to methods for assaying a cell-containing body sample and particularly, but not exclusively, to treating a sample under conditions to cause cell lysis, preferably by means of a detergent; and subjecting the lysed sample to conditions causing the cleavage of nucleic acid molecules. The technology additionally relates to using nucleic acid cleavage conditions to enhance a membrane assay, a device for carrying out such an assay, and a kit for use in the assay.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: August 30, 2022
    Assignee: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
    Inventors: Jostein Holtlund, Andrew Campbell, Stig Morten Borch
  • Patent number: 10830699
    Abstract: A device for determining an assay result may include a test strip, a light source system, a light detection system, and a processor.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: November 10, 2020
    Assignee: Abbott Rapid Diagnostics International Unlimited Company
    Inventors: Stephen P. Sharrock, Andrew P. Phelan
  • Patent number: D922588
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: June 15, 2021
    Assignee: Abbott Rapid Diagnostics International Unlimited Company
    Inventor: Nicholas D. Long
  • Patent number: D960385
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: August 9, 2022
    Assignee: Abbott Rapid Diagnostics International Unlimited Company
    Inventors: Axel Schubert, Thomas Ullrich, Sören Geist, Martin Stohr, Christopher Deppisch, Michael Winterot, Ilka Schlesiger
  • Patent number: D983992
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: April 18, 2023
    Assignee: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
    Inventors: Carsten Buenning, Xin Wu